comparemela.com
Home
Live Updates
GSK's $2-billion purchase of Bellus delivers second big exit
GSK's $2-billion purchase of Bellus delivers second big exit
GSK's $2-billion purchase of Bellus delivers second big exit for Montreal's Bellini family
Deal comes 22 years and multiple setbacks after sale of BioChem Pharma for $5.9-billion
Related Keywords
Montreal ,
Quebec ,
Canada ,
Japan ,
United Kingdom ,
China ,
Toronto ,
Ontario ,
Canadian ,
British ,
Francesco Bellini ,
Brian Bloom ,
Luke Miels ,
Piper Sandler ,
Roberto Bellini ,
Merck Co ,
Drug Administration ,
Biochem Pharma Inc ,
Clementia Pharmaceuticals Inc ,
Power Corp ,
Esther Gibbons Courtesy Of Bellus Health Inc ,
Nasdaq ,
Bellus Health Inc ,
Neurochem Inc ,
Neomed Institute ,
Shire Pharmaceuticals Group ,
Bayer Ag ,
Japan Shionogi Co ,
Baylis Medical Co ,
Astrazeneca ,
Trillium Therapeutics Inc ,
Bloom Burton Co ,
Bellus Health ,
Biochem Pharma ,
Monday Nasdaq ,
Trillium Therapeutics ,
Baylis Medical ,
Commercial Officer Luke Miels ,
Bloom Burton ,
Aud Url ,
Drug ,
Bellus ,
Inc ,
Gsk ,
People ,
Company ,
Development ,
Cough ,
Laval ,